Mizuho Securities USA’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-651,251
Closed -$6.6M 140
2018
Q3
$6.6M Buy
651,251
+425,835
+189% +$4.3M 0.5% 19
2018
Q2
$2.26M Buy
+225,416
New +$2.26M 0.23% 68

Mizuho Securities USA's ORGO Position: Q4 2018 in Review

Mizuho Securities USA sold out of Organogenesis Holdings (ORGO) in Q4 2018, closing a stake of 651,251 shares — an estimated $6.6M sold.

Mizuho Securities USA first reported a position in ORGO in Q2 2018 and held it in 2 quarters. The position peaked at $6.6M in Q3 2018. 0 funds tracked by Wall St. Rank hold ORGO as of Q4 2018.

  • Mizuho Securities USA reported no remaining Organogenesis Holdings position as of Q4 2018 after selling out during the quarter.
  • Mizuho Securities USA sold 651,251 Organogenesis Holdings shares in Q4 2018, an estimated $6.6M.
  • Mizuho Securities USA first reported a position in Organogenesis Holdings in Q2 2018 and held it in 2 quarters.
  • Mizuho Securities USA's Organogenesis Holdings position peaked at $6.6M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2018.

Based on Mizuho Securities USA's 13F filing for Q4 2018, filed 4 Feb 2019.